Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity - Pyle, CJ; Labeur-Iurman, L; Groves, HT; Puttur, F; Lloyd, CM; Tregoning, JS; Harker, JA (Journal of Experimental Medicine, 2021)